PAYER ADVISORY PROGRAM

The complexity of the medical billing and coding in U.S. healthcare system leads to an excessive amount of errors from both HCPs and payers that result in a loss of medical dollars and extreme frustration in the healthcare system. Manufacturers need to clearly communicate clinical and billing information related to their drugs, based on trusted third-party sources.

RJ Health provides an advisory service where manufacturers can deliver custom messaging to over 100 health plan clients and their stakeholders, representing roughly 130 million lives. Minimize the common denials that many medical benefit drugs face when updates are introduced with concise communication around medical drug intelligence.

LEARN MORE

Use Payer Advisory Program to:

Reduce denials through clear messaging on product pricing, coding or reimbursement updates

Manage competitive pricing trends and how this intersects with product access in your landscape

Ensure timely and appropriate reimbursement for HCPCS and CPT coded products

Engage the payers that will help move the needle in specific geographies and trigger direct communication

Reach payer decision-makers that represent over 100 orgs and 130 million lives, including 80% of BCBS plans

Keep payers and providers informed about my pricing & coding updates

RJ Health provides an advisory service where manufacturers can deliver custom messaging to over 100 health plan clients, representing roughly 130 million lives
Concise communication around medical drug intelligence provides correct reimbursement, coding and pricing information to the key decision-makers that you need to influence
Key information included: HCPCS/CPT code, Indications for use, Related ICD-10-CM codes, Administration codes, Pricing information

Reduce denials with targeted messaging around your latest coding data

Manufacturers need to reach payer decision-makers and clearly communicate clinical and billing information related to their drugs, based on trusted third-party sources – and avoid denials
Reduce denials through clear messaging on product pricing, coding or reimbursement updates
Ensure timely and appropriate reimbursement for HCPCS and CPT coded products

Manage competitive pricing trends that intersect with patient access data

Connecting to this vast community of payers minimizes the common denials that many medical benefit drugs face when updates are introduced
Deploy direct communications to the payers that matter, especially when in a highly active competitive landscape where competitors are introducing pricing updates frequently